Iona Walton
Could upadacitinib provide greater benefits than methotrexate? Results of a new trial are in…
A drug called upadacitinib may have better results than methotrexate, the most commonly used initial therapy for rheumatoid arthritis, according to a new trial in Arthritis & Rheumatology. Continue reading
Fibromyalgia is more likely in people with a common form of back arthritis
People with axial spondyloarthritis should consider that they may also have fibromyalgia, as one of the first evidence reviews in the area shows that the risk may be high. Continue reading
Selenium is essential element for good bone health – evidence review
The chemical element selenium may be toxic in large amounts, but tiny quantities are vital for normal cell function in animals, which is why is found in multivitamins. Now a review of the evidence in a leading academic journal shows that selenium deficiency is associated with increased bone turnover, reduced bone mineral density and heightened risk of bone disease. Continue reading
Tiny scorpion-derived proteins deliver arthritis drugs to joints
A minute protein in scorpion venom that rapidly accumulates in joint cartilage has been linked with steroids to reverse arthritis inflammation in arthritis. The drugs concentrated in the joints, potentially avoiding the body-wide toxicities and infection risks caused by non-targeted treatment. Continue reading
A quick diagnosis of knee osteoarthritis was followed by a lengthy wait for surgery, actor Peter Egan explains
Success in the acting business tends to hinge on maintaining physical health and in November 2013, when his right knee showed sudden signs of deterioration, Peter Egan was in high demand. Continue reading
